A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Public ClinicalTrials.gov record NCT07223840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for Reduction in Risk of Relapse to Cigarette Smoking in Adults (RENEW-Smk-1)
Study identification
- NCT ID
- NCT07223840
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 222 participants
Conditions and interventions
Conditions
Interventions
- Brenipatide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2, 2025
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
- Last update posted
- Apr 16, 2026
2025 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland Research Northwest | Rogers | Arkansas | 72758 | Recruiting |
| Hillcrest Medical Research | DeLand | Florida | 32720 | Recruiting |
| TecTum Research | Hollywood | Florida | 33024 | Recruiting |
| K2 Medical Research ORLANDO | Maitland | Florida | 32751 | Recruiting |
| GTL Medical & Research Group | Miami | Florida | 33173 | Recruiting |
| North Georgia Clinical Research | Woodstock | Georgia | 30189 | Recruiting |
| Revival Research Institute, LLC | Dearborn | Michigan | 48126 | Recruiting |
| Arch Clinical Trials | St Louis | Missouri | 63141 | Recruiting |
| Vector Clinical Trials | Las Vegas | Nevada | 89128 | Recruiting |
| Rochester Clinical Research, LLC | Rochester | New York | 14609 | Recruiting |
| Coastal Carolina Research Center | North Charleston | South Carolina | 29405 | Recruiting |
| Circle Clinical Research | Sioux Falls | South Dakota | 57104 | Recruiting |
| FutureSearch Trials of Dallas | Dallas | Texas | 75251 | Recruiting |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77054 | Recruiting |
| Health Research of Hampton Roads, Inc. | Newport News | Virginia | 23606 | Recruiting |
| Eastside Research Associates | Redmond | Washington | 98052 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07223840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07223840 live on ClinicalTrials.gov.